News from enterome A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 03, 2019, 03:00 ET Enterome Expands and Strengthens its Management Team

ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the key functional and molecular interactions between the...


Mar 27, 2019, 04:00 ET Enterome to Present Data on Its Innovative Microbiome-derived Molecular Mimicry Approach to Cancer Immunotherapy at AACR 2019

Enterome SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the key functional and molecular interactions between the...


Oct 23, 2018, 02:00 ET Enterome Signs Global Licensing, Co-development and Co-promotion Agreement with Takeda for the Treatment of Crohn's Disease

EB8018, the lead investigational candidate, targets Crohn's disease with potential for other GI disorders ENTEROME SA, a clinical-stage biotech...


Aug 02, 2018, 03:00 ET Enterome CEO to Present at Two Upcoming Investor Conferences in the United States

Enterome SA, a clinical-stage biotechnology company pioneering innovative therapies to treat microbiome-associated diseases with a focus on...


Jun 04, 2018, 03:00 ET Enterome to Attend the Jefferies 2018 Global Healthcare Conference in New York

Enterome SA, a clinical-stage biotechnology company pioneering innovative therapies to treat microbiome-associated diseases with a focus on...


Jun 01, 2018, 03:00 ET Enterome to Feature Promising Phase 1 Clinical Data With its Lead Candidate EB8018 for Crohn's Disease at the Digestive Disease Week 2018

Enterome SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory...


Mar 12, 2018, 04:00 ET Enterome to Present at the Cowen and Company 38th Annual Healthcare Conference

Enterome SA, a clinical-stage biotech company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory...


Jan 04, 2018, 03:00 ET Enterome Raises €32 Million ($38.5 Million) in a Series D Financing

- Proceeds will be used to progress lead development programs - EB8018 for IBD and EO2315 for cancer - Secures €40 million loan facility ($48...


Oct 27, 2017, 03:00 ET Enterome's EB8018, a First-in-class Drug Candidate Targeting Crohn's Disease, Successfully Completes Phase I Study in Healthy Volunteers

ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, is pleased to announce the successful completion of the first Phase 1 ...


Sep 20, 2017, 03:00 ET Enterome to Move its Research Laboratories to Genopole, France's First Biocluster

ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, announced today that the Company is moving its research laboratories...


Jul 12, 2017, 03:00 ET Enterome Appoints Mary Thistle to its Board of Directors

ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, is pleased to announce that Mary Thistle has joined the Enterome...


Jul 11, 2017, 02:00 ET Enterome and Nestlé Health Science Launch New Diagnostics Company

ENTEROME SA, a pioneer of innovative therapies for microbiome-related diseases, and Nestlé Health Science, announce the joint creation of Microbiome...


Dec 09, 2016, 03:00 ET Enterome Further Strengthens its Leadership Team and Board Adding Clinical Development Experience

Jai Patel appointed as Chief Medical Officer and Roger J. Garceau elected to the Board Enterome SA, a pioneer in the development of pharmaceuticals...


Nov 03, 2016, 04:00 ET Enterome Appoints Christophe Bonny as Chief Scientific Officer

ENTEROME Bioscience SA, a pioneer in the development of pharmaceuticals and diagnostics based on the gut microbiome, is pleased to announce that it...